AN2 THERAPEUTICS INC (ANTX) Stock Income Statement
NASDAQ:ANTX - Nasdaq - US0373261058 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 54.55M | 69.64M | 42.26M | 21.57M | 7.28M | |||
| Research and Development | 40.49M | 54.87M | 29.51M | 16.91M | 6.02M | |||
| Selling, General, and Administrative Expenses | 14.07M | 14.76M | 12.75M | 4.67M | 1.27M | |||
| Operating Income | -54.55M | -69.64M | -42.26M | -21.57M | -7.28M | |||
| Interest Income/Expense | 5.47M | N/A | 1.35M | 70.00K | 0.00 | |||
| Other Income/Expense | 0.00 | 4.90M | -50.00K | -40.00K | -6.32M | |||
| Non Recurring Items | -2.23M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -51.32M | -64.73M | -40.96M | -21.54M | -13.60M | |||
| Net Income | -51.32M | -64.73M | -42.78M | -28.06M | -14.58M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.72 | -2.74 | -2.79 | -1.50 | -0.78 | |||
| Non GAAP EPS | -1.64 | -2.82 | -4.71 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD